Bianca Balbino

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Cross-species cellular mapping and humanization of Fcγ receptors to advance antibody modeling.

Cross-species cellular mapping and humanization of Fcγ receptors to advance antibody modeling.

Journal: Science immunology

Published: January 30, 2026

Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studies.

Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studies.

Journal: mAbs

Published: July 08, 2025

Differential effects of FcRn antagonists on the subcellular trafficking of FcRn and albumin.

Differential effects of FcRn antagonists on the subcellular trafficking of FcRn and albumin.

Journal: JCI insight

Published: October 04, 2023

Bullous pemphigoid induced by IgG targeting type XVII collagen non-NC16A/NC15A extracellular domains is driven by Fc gamma receptor- and complement-mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade.

Bullous pemphigoid induced by IgG targeting type XVII collagen non-NC16A/NC15A extracellular domains is driven by Fc gamma receptor- and complement-mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade.

Journal: The Journal of pathology

Published: May 31, 2023

The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement.

The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement.

Journal: Nature communications

Published: February 21, 2022

FcRn Antagonism Leads to a Decrease of Desmoglein-Specific B Cells: Secondary Analysis of a Phase 2 Study of Efgartigimod in Pemphigus Vulgaris and Pemphigus Foliaceus.

FcRn Antagonism Leads to a Decrease of Desmoglein-Specific B Cells: Secondary Analysis of a Phase 2 Study of Efgartigimod in Pemphigus Vulgaris and Pemphigus Foliaceus.

Journal: Frontiers in immunology

Published: January 26, 2022

IgE in the pathophysiology and therapy of food allergy.

IgE in the pathophysiology and therapy of food allergy.

Journal: European journal of immunology

Published: September 30, 2020

Neutrophil-specific gain-of-function mutations in Nlrp3 promote development of cryopyrin-associated periodic syndrome.

Neutrophil-specific gain-of-function mutations in Nlrp3 promote development of cryopyrin-associated periodic syndrome.

Journal: The Journal of experimental medicine

Published: July 10, 2020

Dual vaccination against IL-4 and IL-13 protects against chronic allergic asthma in mice.

Dual vaccination against IL-4 and IL-13 protects against chronic allergic asthma in mice.

Journal: Nature communications

Published: June 26, 2020

A highly sensitive bioluminescent method for measuring allergen-specific IgE in microliter samples.

A highly sensitive bioluminescent method for measuring allergen-specific IgE in microliter samples.

Journal: Allergy

Published: May 15, 2020

The anti-IgE mAb omalizumab induces adverse reactions by engaging Fcγ receptors.

The anti-IgE mAb omalizumab induces adverse reactions by engaging Fcγ receptors.

Journal: The Journal of clinical investigation

Published: April 22, 2019

Approaches to target IgE antibodies in allergic diseases.

Approaches to target IgE antibodies in allergic diseases.

Journal: Pharmacology & therapeutics

Published: April 02, 2018

Showing 1-12 of 17

Last Updated: 09/26/2026